BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 27180964)

  • 1. [Treatment of nephrotic syndrome: immuno- or rather podocyte therapy?].
    Lewko B
    Postepy Hig Med Dosw (Online); 2016 May; 70():459-70. PubMed ID: 27180964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podocyte-associated talin1 is critical for glomerular filtration barrier maintenance.
    Tian X; Kim JJ; Monkley SM; Gotoh N; Nandez R; Soda K; Inoue K; Balkin DM; Hassan H; Son SH; Lee Y; Moeckel G; Calderwood DA; Holzman LB; Critchley DR; Zent R; Reiser J; Ishibe S
    J Clin Invest; 2014 Mar; 124(3):1098-113. PubMed ID: 24531545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cathepsin L in idiopathic nephrotic syndrome in children.
    Keisuke S; Kohei M; Takuji E; Tomoki M; Yuichi M; Rina O; Tsukasa T; Mitsuru O
    Med Hypotheses; 2020 Aug; 141():109718. PubMed ID: 32289645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qi-Dan Fang ameliorates adriamycin-induced nephrotic syndrome rat model by enhancing renal function and inhibiting podocyte injury.
    Wu JB; Ye SF; Liang CL; Li YC; Yu YJ; Lai JM; Lin H; Zheng J; Zhou JY
    J Ethnopharmacol; 2014 Feb; 151(3):1124-1132. PubMed ID: 24389029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of nephrotic syndrome: new insights into molecules acting at the glomerular filtration barrier.
    Zenker M; Machuca E; Antignac C
    J Mol Med (Berl); 2009 Sep; 87(9):849-57. PubMed ID: 19649571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Podocytes are firmly attached to glomerular basement membrane in kidneys with heavy proteinuria.
    Lahdenkari AT; Lounatmaa K; Patrakka J; Holmberg C; Wartiovaara J; Kestilä M; Koskimies O; Jalanko H
    J Am Soc Nephrol; 2004 Oct; 15(10):2611-8. PubMed ID: 15466265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A spectrum of novel anti-vascular endothelial cells autoantibodies in idiopathic nephrotic syndrome patients.
    Ye Q; Wang D; Zhou C; Meng H; Liu H; Mao J
    Clin Immunol; 2023 Apr; 249():109273. PubMed ID: 36863601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of podocytes in glomerular pathobiology.
    Asanuma K; Mundel P
    Clin Exp Nephrol; 2003 Dec; 7(4):255-9. PubMed ID: 14712353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress in the pathogenesis of nephrotic proteinuria.
    Tesar V; Zima T
    Crit Rev Clin Lab Sci; 2008; 45(2):139-220. PubMed ID: 18415815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podocyte RhoGTPases: new therapeutic targets for nephrotic syndrome?
    Saleem MA; Welsh GI
    F1000Res; 2019; 8():. PubMed ID: 31723415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Rho-GTPase binding protein IQGAP2 is required for the glomerular filtration barrier.
    Sugano Y; Lindenmeyer MT; Auberger I; Ziegler U; Segerer S; Cohen CD; Neuhauss SC; Loffing J
    Kidney Int; 2015 Nov; 88(5):1047-56. PubMed ID: 26154927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The glomerular permeability factors in idiopathic nephrotic syndrome.
    Davin JC
    Pediatr Nephrol; 2016 Feb; 31(2):207-15. PubMed ID: 25925039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The podocyte as a direct target of immunosuppressive agents.
    Schönenberger E; Ehrich JH; Haller H; Schiffer M
    Nephrol Dial Transplant; 2011 Jan; 26(1):18-24. PubMed ID: 20937691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of podocyte structure during the development of nephrotic syndrome.
    Smoyer WE; Mundel P
    J Mol Med (Berl); 1998 Mar; 76(3-4):172-83. PubMed ID: 9535550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrotic syndrome in a dish: recent developments in modeling in vitro.
    Veissi S; Smeets B; van den Heuvel LP; Schreuder MF; Jansen J
    Pediatr Nephrol; 2020 Aug; 35(8):1363-1372. PubMed ID: 30820702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podocyte Sphingolipid Signaling in Nephrotic Syndrome.
    Li G; Kidd J; Gehr TWB; Li PL
    Cell Physiol Biochem; 2021 Apr; 55(S4):13-34. PubMed ID: 33861526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foothold of NPHS2 mutations in primary nephrotic syndrome.
    Jaffer AT; Ahmed WU; Raju DS; Jahan P
    J Postgrad Med; 2011; 57(4):314-20. PubMed ID: 22120861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podocyte endocytosis in the regulation of the glomerular filtration barrier.
    Inoue K; Ishibe S
    Am J Physiol Renal Physiol; 2015 Sep; 309(5):F398-405. PubMed ID: 26084928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the IL-2 Receptor in Podocytes: A Potential Mechanism for Podocyte Injury in Idiopathic Nephrotic Syndrome?
    Zea AH; Stewart T; Ascani J; Tate DJ; Finkel-Jimenez B; Wilk A; Reiss K; Smoyer WE; Aviles DH
    PLoS One; 2016; 11(7):e0157907. PubMed ID: 27389192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerular Endothelium and its Impact on Glomerular Filtration Barrier in Diabetes: Are the Gaps Still Illusive?
    Ndisang JF
    Curr Med Chem; 2018; 25(13):1525-1529. PubMed ID: 28685678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.